Natalie A Bello1, Susan Cheng1, Brian Claggett1, Amil M Shah1, Chiadi E Ndumele1, Gabriela Querejeta Roca1, Angela B S Santos1, Deepak Gupta1, Orly Vardeny1, David Aguilar1, Aaron R Folsom1, Kenneth R Butler1, Dalane W Kitzman1, Josef Coresh1, Scott D Solomon2. 1. From the Division of Cardiology, Department of Medicine, Columbia University Medical Center, New York, NY (N.A.B.); Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (S.C., B.C., A.M.S., G.Q.R., A.B.S.S., S.D.S.); Department of Medicine, Johns Hopkins University, Baltimore, MD (C.E.N., J.C.); Department of Medicine, Vanderbilt Heart and Vascular Institute, Vanderbilt University Medical Center, Nashville, TN (D.G.); Pharmacy Practice Division, University of Wisconsin School of Pharmacy, Madison (O.V.); Section of Cardiology, Department of Medicine, Baylor College of Medicine, Houston, TX (D.A.); Division of Epidemiology and Community Health, University of Minnesota, Minneapolis (A.R.F.); Department of Medicine, University of Mississippi Medical Center, Jackson (K.R.B.); and Cardiovascular Medicine Section, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC (D.W.K.). 2. From the Division of Cardiology, Department of Medicine, Columbia University Medical Center, New York, NY (N.A.B.); Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (S.C., B.C., A.M.S., G.Q.R., A.B.S.S., S.D.S.); Department of Medicine, Johns Hopkins University, Baltimore, MD (C.E.N., J.C.); Department of Medicine, Vanderbilt Heart and Vascular Institute, Vanderbilt University Medical Center, Nashville, TN (D.G.); Pharmacy Practice Division, University of Wisconsin School of Pharmacy, Madison (O.V.); Section of Cardiology, Department of Medicine, Baylor College of Medicine, Houston, TX (D.A.); Division of Epidemiology and Community Health, University of Minnesota, Minneapolis (A.R.F.); Department of Medicine, University of Mississippi Medical Center, Jackson (K.R.B.); and Cardiovascular Medicine Section, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC (D.W.K.). ssolomon@rics.bwh.harvard.edu.
Abstract
BACKGROUND: Obesity increases cardiovascular risk. However, the extent to which various measures of body composition are associated with abnormalities in cardiac structure and function, independent of comorbidities commonly affecting obese individuals, is not clear. This study sought to examine the relationship between body mass index, waist circumference, and percent body fat with conventional and advanced measures of cardiac structure and function. METHODS AND RESULTS: We studied 4343 participants of the ARIC study (Atherosclerosis Risk in Communities) who were aged 69 to 82 years, free of coronary heart disease and heart failure, and underwent comprehensive echocardiography. Increasing body mass index, waist circumference, and body fat were associated with greater left ventricular (LV) mass and left atrial volume indexed to height(2.7) in both men and women (P<0.001). In women, all 3 measures were associated with abnormal LV geometry, and increasing waist circumference and body fat were associated with worse global longitudinal strain, a measure of LV systolic function. In both sexes, increasing body mass index was associated with greater right ventricular end-diastolic area and worse right ventricular fractional area change (P≤0.001). We observed similar associations for both waist circumference and percent body fat. CONCLUSIONS: In a large, biracial cohort of older adults free of clinically overt coronary heart disease or heart failure, obesity was associated with subclinical abnormalities in cardiac structure in both men and women and with adverse LV remodeling and impaired LV systolic function in women. These data highlight the association of obesity and subclinical abnormalities of cardiac structure and function, particularly in women.
BACKGROUND:Obesity increases cardiovascular risk. However, the extent to which various measures of body composition are associated with abnormalities in cardiac structure and function, independent of comorbidities commonly affecting obese individuals, is not clear. This study sought to examine the relationship between body mass index, waist circumference, and percent body fat with conventional and advanced measures of cardiac structure and function. METHODS AND RESULTS: We studied 4343 participants of the ARIC study (Atherosclerosis Risk in Communities) who were aged 69 to 82 years, free of coronary heart disease and heart failure, and underwent comprehensive echocardiography. Increasing body mass index, waist circumference, and body fat were associated with greater left ventricular (LV) mass and left atrial volume indexed to height(2.7) in both men and women (P<0.001). In women, all 3 measures were associated with abnormal LV geometry, and increasing waist circumference and body fat were associated with worse global longitudinal strain, a measure of LV systolic function. In both sexes, increasing body mass index was associated with greater right ventricular end-diastolic area and worse right ventricular fractional area change (P≤0.001). We observed similar associations for both waist circumference and percent body fat. CONCLUSIONS: In a large, biracial cohort of older adults free of clinically overt coronary heart disease or heart failure, obesity was associated with subclinical abnormalities in cardiac structure in both men and women and with adverse LV remodeling and impaired LV systolic function in women. These data highlight the association of obesity and subclinical abnormalities of cardiac structure and function, particularly in women.
Authors: Roberto M Lang; Michelle Bierig; Richard B Devereux; Frank A Flachskampf; Elyse Foster; Patricia A Pellikka; Michael H Picard; Mary J Roman; James Seward; Jack S Shanewise; Scott D Solomon; Kirk T Spencer; Martin St John Sutton; William J Stewart Journal: J Am Soc Echocardiogr Date: 2005-12 Impact factor: 5.251
Authors: Sherma Zibadi; Felina Cordova; Elise H Slack; Ronald R Watson; Douglas F Larson Journal: Cardiovasc Toxicol Date: 2011-12 Impact factor: 3.231
Authors: Carl J Lavie; Richard V Milani; Hector O Ventura; Gustavo A Cardenas; Mandeep R Mehra; Franz H Messerli Journal: Am J Cardiol Date: 2007-08-27 Impact factor: 2.778
Authors: Carl J Lavie; Martin A Alpert; Ross Arena; Mandeep R Mehra; Richard V Milani; Hector O Ventura Journal: JACC Heart Fail Date: 2013-04-01 Impact factor: 12.035
Authors: Vishal N Rao; Di Zhao; Matthew A Allison; Eliseo Guallar; Kavita Sharma; Michael H Criqui; Mary Cushman; Roger S Blumenthal; Erin D Michos Journal: JACC Heart Fail Date: 2018-10-10 Impact factor: 12.035
Authors: Masaru Obokata; Yogesh N V Reddy; Sorin V Pislaru; Vojtech Melenovsky; Barry A Borlaug Journal: Circulation Date: 2017-04-05 Impact factor: 29.690
Authors: Kershaw V Patel; Matthew W Segar; Carl J Lavie; Nitin Kondamudi; Ian J Neeland; Jaime P Almandoz; Corby K Martin; Salvatore Carbone; Javed Butler; Tiffany M Powell-Wiley; Ambarish Pandey Journal: Circulation Date: 2021-12-03 Impact factor: 29.690
Authors: Andrea Sonaglioni; Gian Luigi Nicolosi; Roberta Trevisan; Alberto Granato; Maurizio Zompatori; Michele Lombardo Journal: Intern Emerg Med Date: 2022-06-26 Impact factor: 5.472
Authors: Mark J Haykowsky; Barbara J Nicklas; Peter H Brubaker; W Gregory Hundley; Tina E Brinkley; Bharathi Upadhya; J Thomas Becton; Michael D Nelson; Haiying Chen; Dalane W Kitzman Journal: JACC Heart Fail Date: 2018-07-11 Impact factor: 12.035
Authors: Katlyn E Koepp; Masaru Obokata; Yogesh N V Reddy; Thomas P Olson; Barry A Borlaug Journal: JACC Heart Fail Date: 2020-07-08 Impact factor: 12.035